GL1X · GenesisL1 explorer

MolNFT v1 · #40762 · protein

Crystal structure of a human factor xa inhibitor complex

2J2U · Coagulation factor X heavy chain: “Crystal structure of a human factor xa inhibitor complex”. X-ray diffraction, 1 ligand (GSQ), 2 pockets (best druggability 0.46). MolNFT v1 #40762 on GenesisL1: 3D structure, binding sites and…

PDB
2J2U
Type
protein
Length
281 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Coagulation factor X heavy chain; Coagulation factor X light chain
EC
3.4.21.6
UniProt
P00742
Ligands
GSQ
Pockets
2 · best druggability 0.46

Structure

x-ray diffraction · 2 distinct chains · 14% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACoagulation factor X heavy chain (EC 3.4.21.6)protein22914% helix, 36% strandP00742
BCoagulation factor X light chain (EC 3.4.21.6)protein5213% helix, 31% strandP00742

Ligands and binding sites

  • GSQ · 5-chloro-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-5-chloro-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-sulfonamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11660.460.7528empty
21270.450.7724GSQ

Interfaces

1 interface between chains.

  • A–B · 915 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 2J2U · Crystal structure of a human factor xa inhibitor complex · the same entry in another collection · chain A against A, TM-score 1.00
  • P00742 · AlphaFold monomer V2.0 prediction for coagulation factor X (P00742) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.